Amiodarone Use and All‐Cause Mortality in Patients With a Continuous‐Flow Left Ventricular Assist Device

BACKGROUND: Atrial and ventricular arrhythmias are commonly encountered in patients with advanced heart failure, with amiodarone being the most commonly used antiarrhythmic drug in continuous‐flow left ventricular assist device (CF‐LVAD) recipients. The purpose of this study was to assess the impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Gopinathannair, Rakesh, Pothineni, Naga Venkata K., Trivedi, Jaimin R., Roukoz, Henri, Cowger, Jennifer, Ahmed, Mustafa M., Bhan, Adarsh, K. Ravichandran, Ashwin, Bhat, Geetha, Al Ahmad, Amin, Natale, Andrea, Di Biase, Luigi, Slaughter, Mark S., Lakkireddy, Dhanunjaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238747/
https://www.ncbi.nlm.nih.gov/pubmed/35656998
http://dx.doi.org/10.1161/JAHA.121.023762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238747/
https://www.ncbi.nlm.nih.gov/pubmed/35656998
http://dx.doi.org/10.1161/JAHA.121.023762

Ejemplares similares